NexgenRx Inc.
NXG.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 996.57% | 7.43% | 93.09% | 212.21% | 464.06% |
| Total Depreciation and Amortization | -0.89% | -7.48% | 11.55% | -5.41% | -5.99% |
| Total Amortization of Deferred Charges | -- | -- | -9.14% | -- | -- |
| Total Other Non-Cash Items | -172.33% | -26.76% | 336.55% | -83.02% | 278.65% |
| Change in Net Operating Assets | -41.63% | 65.53% | -229.64% | -158.76% | 109.59% |
| Cash from Operations | 0.94% | 162.92% | -41.12% | -81.62% | 62.09% |
| Capital Expenditure | -729.78% | -72.99% | -136.78% | 85.89% | -435.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.62% | -37.50% | -- | -- | 26.59% |
| Cash from Investing | -136.00% | -48.33% | -2,198.85% | -24.18% | 11.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -41.08% | -64.25% | -13.55% | -53.18% | -39.31% |
| Issuance of Common Stock | -- | -- | -- | 0.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.85% | 6.12% | 76.34% | 1.63% | 8.88% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.50% | -188.28% | 78.22% | -341.76% | 7.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.41% | 134.61% | -123.15% | -94.84% | 8,305.13% |